
A new technique has been developed to test chromosomal abnormality from blood samples, doing away with the need for aminocentesis. Thus Down' syndrome detection becomes that much easier.
Amniocentesis involves inserting a long needle through the mother's abdomen and drawing fluid from the womb.
Advertisement
The procedure carries a small risk of miscarriage or infection as well as being uncomfortable. Approximately one in 100 women who have the test will miscarry as a result, according to the Royal College of Obstetricians and Gynaecologists.
The new technique allowed scientists to pinpoint signs of chromosomal abnormality in a study of 18 pregnant women.
Down's syndrome occurs when a foetus has three copies of chromosome 21 instead of two. It can cause physical and intellectual impairments.
If a foetus has three copies of chromosome 21 rather than the normal two, there will also be a relative increase in the quantity of chromosome 21 in the mother's blood.
Professor Stephen Quake, from Stanford University, California, who led the new study, said: "Non-invasive testing will be much safer than current approaches.
"The earlier you know you've got a foetus with Down syndrome, the better able you are to prepare."
Carol Boys, chief executive of the Down's Syndrome Association, told BBC news: "There is no question that these non-invasive tests will be introduced in the next few years.
"It's therefore incredibly important that potential parents are given accurate information on Down's syndrome before they make a choice about whether to terminate or not.
"We don't consider Down's syndrome a reason for termination but we recognise that bringing up a child with Down's syndrome isn't right for everyone."
The research is reported in the journal Proceedings of the National Academy of Sciences.
Source: AFP
GPL/L
Down's syndrome occurs when a foetus has three copies of chromosome 21 instead of two. It can cause physical and intellectual impairments.
Advertisement
If a foetus has three copies of chromosome 21 rather than the normal two, there will also be a relative increase in the quantity of chromosome 21 in the mother's blood.
Professor Stephen Quake, from Stanford University, California, who led the new study, said: "Non-invasive testing will be much safer than current approaches.
"The earlier you know you've got a foetus with Down syndrome, the better able you are to prepare."
Carol Boys, chief executive of the Down's Syndrome Association, told BBC news: "There is no question that these non-invasive tests will be introduced in the next few years.
"It's therefore incredibly important that potential parents are given accurate information on Down's syndrome before they make a choice about whether to terminate or not.
"We don't consider Down's syndrome a reason for termination but we recognise that bringing up a child with Down's syndrome isn't right for everyone."
The research is reported in the journal Proceedings of the National Academy of Sciences.
Source: AFP
GPL/L
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Research News

Tobacco smoke contains toxic chemicals which damage lungs, weaken the immune system and cause tuberculosis.

Identifying an unappreciated relationship between brain shape and activity overturns the century-old paradigm emphasizing the importance of complex brain connectivity.

Decoding the eight factors affecting Black adults' life expectancy.

Sobering truth about foot travel in the United States emerges from international statistics, highlighting the prevalence of walking on the Blacksburg campus.

Unveiling a hidden mechanism, proteins within brain cells exhibit newfound abilities at synapses, reinforcing Darwin's theory of adaptation and diversity in the natural world.